School of Medicine

Researchers at Washington University have developed a noninvasive technology combining a holographic acoustic device with genetic engineering that allows them to precisely target affected neurons in the brain.

In a new study, a team of researchers at Washington University School of Medicine in St. Louis reports that a drug approved by the FDA for another condition may stabilize vision for patients with RVCL-S, a rare genetic disease.

School of Medicine researchers have joined an international study aimed at understanding the gene changes that may lead to Parkinson’s disease in Black and African American people.

Brendan P. Lucey, MD, a professor of neurology at the School of Medicine, has been awarded the 2024 Sleep Science Award from the American Academy of Neurology in recognition of his distinguished contributions to the neurology and neuroscience of sleep.

Naresha Saligrama, an assistant professor of neurology at the School of Medicine, has received a $200,000 grant from the Cure Alzheimer’s Fund to investigate whether other aspects of the immune system also contribute to the disease, specifically T cells.

New research from Washington University School of Medicine in St. Louis may help offer treatment options for pregnant people with substance use disorders. The study indicates that patients with opioid use disorders and ADHD who remain on ADHD medications during pregnancy are far more likely to adhere to treatment, and far less likely to overdose.

A new project called NutriConnect, led by Jing Li, MD, DrPH, of Washington University School of Medicine in St. Louis, will compare the effectiveness of two produce prescription approaches for encouraging healthy eating and addressing food insecurity.

John F. DiPersio, MD, PhD, the Virginia E. and Sam J. Golman Endowed Professor of Medicine at Washington University School of Medicine in St. Louis, has received the Chancellor’s Award for Innovation and Entrepreneurship for his research contributions.

Adam Wilcox, a professor of medicine at Washington University School of Medicine in St. Louis, has been named the chair of the Patient-Centered Outcomes Research Institute Methodology Committee.

New research from Washington University School of Medicine in St. Louis and other institutions supports earlier findings that indicate that anesthesia is no more hazardous for the brain at higher doses than at lower doses.